Back to the main directory
EarningsReview / Equity
- Vitrolife (Hold, TP: SEK205.00) - Profit warning due to coronavirus by DnB Markets
- Atlantic Sapphire (Buy, TP: NOK150.00) - Mortality, refinancing, insiders buying by DnB Markets
- Novo Nordisk (Buy, TP: DKK500.00) - Too-conservative aspirations by DnB Markets
- FY19: puts and takes by BNP Paribas
- Sunshine and Sustainability by BNP Paribas
- At this price, we''d buy them all by BNP Paribas
- A future without OandG? by BNP Paribas
- Yanghe Brewery (002304 CH) by HSBC
- 洋河股份（002304 CH） by HSBC
- 信维通信（300136 CH） by HSBC
- S.F. Holding (002352 CH) by HSBC
- Revolving credit - the last litigation front? by BNP Paribas
- Itaú BBA on LATAM Airlines Group: Solid 4Q19 Results by Itau
- More time; more money by BNP Paribas
- The strength to resist by BNP Paribas
- D/S Norden - New dividend policy – at least 50% payout ratio by Danske Bank Equity Research
- Better Net Debt, but guidance not encouraging by BNP Paribas
- Spar Nord - Plain-vanilla story with income relief set to arrive soon by Danske Bank Equity Research
- Sydbank - Income stability and credit quality excellence by Danske Bank Equity Research
- Telenor (Buy, TP: NOK180.00) - Eyeing the digital telco prize by DnB Markets
- Nordic Capital Goods dashboard - March 2020 by DnB Markets
- Hikma Pharma (HIK LN) by HSBC
- Making steady progress by BNP Paribas
- Ericsson, Huawei, Nokia share wars intensify by BNP Paribas
- Enough is enough? by BNP Paribas